Zogenix, Inc.’s Zohydro ER – New drugs approved for excruciating pains
However, it will be better if it doesn’t arrive in the market before the new formulation is complete. Zohydro ER will surely... Read More
+91 789 2456 581 | info@nckpharma.com
Sign In
|Sign Up
Please sign in first
Not a member?
Please simply create an account before buying/booking any courses.
Create an account for free!
- Home
- NCK services
- Course List
- Executive Program
- Advance Diploma Program
- Advance Diploma Dual Specialization
- Certificate Courses – 1 Month
- Biotech Regulatory Affairs & Strategic Management
- Pharma Product Management
- Pharma Project Management
- Medical Devices Regulation
- Drug Regulatory Affairs
- Latam DRA
- African DRA
- GCC Regulatory Affairs
- ASEAN DRA
- European DRA
- USFDA Regulation
- GMP & GMP Audit
- Dossier Training
- Drug Discovery to Commercialization
- QA Documentation
- IP Management
- Short Courses / Books / White Paper
- Admission Process
- Knowledge Base
- Contact
Tag
Approval Status of Zohydro ER
Our Popular Courses
Like us in Facebook
Recent Articles
- Grünenthal entering into US market with acquisition of US based Averitas Pharma
- Pharma Disinvestment deal: AstraZeneca to divest Synagis US rights to Sobi
- Pharma R&D Deal Termination: Daiichi Sankyo & GSK’s vaccine JV in Japan
- Insight on Strides – SUDA Pharma Strategic Deal
- How much is the ideal royalty payment in pharmaceutical industry?
- Hikma Pharmaceuticals and Vectura codevelopment and commercialization of GSK’s Breo Ellipta generics
- Pharma acquisition Insight: Hikma Pharmaceuticals to acquire Medlac Pharma
- Secarna enters co-development pact with MetP Pharma for transnasally delivered antisense oligonucleotide-based CNS therapeutics
- Glenmark’s anti-myeloma drug to start phase 1 trial in solid tumors
- Glenmark’S Exclusive Collaboration Agreement with SCD Pharmaceuticals, South Korea for Ophthalmic Solution Products